The PCI Center

Filter Your Results




The Role of Stent Biomaterials In Reducing DAPT Duration

Hiroyuki Jinnouchi, MD; Renu Virmani, MD; and Aloke V. Finn, MD

March/April 2019—Expert commentary on the roles of technology and pharmacology.

Case Report: The Safety of Drug-Eluting Stents in High Bleeding Risk Patients

José Francisco Díaz Fernández, MD, FESC; and Santiago Camacho Freire, MD

March/April 2019—When anatomically complex meets clinically complex.

Case Report: Triple Therapy in a Patient With High Bleeding Risk After PCI

Yoshihisa Nakagawa, MD, PhD

March/April 2019—For patients on chronic oral anticoagulation (OAC) who are undergoing percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT; aspirin and a P2Y12 inhibitor)…

Case Report: Antiplatelet Therapy After Complex PCI in the Anticoagulated Patient

Michael P. Savage, MD, FACC, FSCAI, FACP; David L. Fischman, MD, FACC, FACP; and Marguerite Davis, BS, RT(R), RCIS

March/April 2019—The optimal strategy for antiplatelet therapy in patients treated with coronary drug-eluting stents (DESs) who require anticoagulation has been an issue fraught with uncertain…

Medtronic Launches Telescope Guide Extension Catheter for Use in Complex Coronary Cases

May 16, 2019 -- Medtronic announced the global launch of its first device in the guide extension catheter market. The Telescope guide extension catheter provides interventiona…

Staged PCI for Complete Revascularization Compared With Culprit Vessel–Only PCI for STEMI and Multivessel CAD

May 14, 2019 -- Investigators conducted a study in China that compared the benefit and long-term outcomes of staged percutaneous coronary intervention (PCI) for complete revas…

Cordis Launches Radial 360 Portfolio for Interventional Cardiology Procedures

May 14, 2019 -- Cordis, a Cardinal Health company, announced the full launch of its Radial 360 portfolio in the United States. The Radial 360 portfolio offers a complete range…

Long-Term Follow-Up Data Published for Occlutech's Figulla Percutaneous PFO Occluder

May 13, 2019 -- A Dutch analysis of the safety and efficacy of the Figulla patent foramen ovale (PFO) occluder (Occlutech International AB) with long-term follow-up of approxi…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.